Biogenesis of phased siRNAs on membrane-bound polysomes in Arabidopsis
Abstract
Small RNAs are central players in RNA silencing, yet their cytoplasmic compartmentalization and the effects it may have on their activities have not been studied at the genomic scale. Here we report that Arabidopsis microRNAs (miRNAs) and small interfering RNAs (siRNAs) are distinctly partitioned between the endoplasmic reticulum (ER) and cytosol. All miRNAs are associated with membrane-bound polysomes (MBPs) as opposed to polysomes in general. The MBP association is functionally linked to a deeply conserved and tightly regulated activity of miRNAs – production of phased siRNAs (phasiRNAs) from select target RNAs. The phasiRNA precursor RNAs, thought to be noncoding, are on MBPs and are occupied by ribosomes in a manner that supports miRNA-triggered phasiRNA production, suggesting that ribosomes on the rough ER impact siRNA biogenesis. This study reveals global patterns of cytoplasmic partitioning of small RNAs and expands the known functions of ribosomes and ER.
https://doi.org/10.7554/eLife.22750.001Introduction
RNA silencing is a conserved posttranscriptional gene regulatory mechanism in eukaryotes. At the core of RNA silencing are small RNAs, microRNAs (miRNAs) or small interfering RNAs (siRNAs), and their effector ARGONAUTE (AGO) proteins. Many observations document the membrane association of plant and animal AGO proteins (Brodersen et al., 2012; Cikaluk et al., 1999; Gibbings et al., 2009; Jouannet et al., 2012; Lee et al., 2009; Li et al., 2013; Stalder et al., 2013; Wu et al., 2013), but the cytoplasmic location where miRNAs or siRNAs repress target RNAs is largely unexplored and is perhaps presumed to be the cytosol. The membrane-cytosol partitioning of small RNAs has not been studied at the genomic scale. Little is known about how the membrane-cytosol partitioning of small RNAs affects their activities.
A well-documented feature of RNA silencing in plants and C. elegans is signal amplification, in which primary siRNAs from transgenes or viruses guide the production of secondary siRNAs from target RNAs through the activities of RNA-dependent RNA polymerases (RdRP) (Sijen et al., 2001; Vaistij et al., 2002). This results in enhanced silencing and the spreading of the silencing signal into flanking sequences. Contrary to siRNAs, most miRNAs do not cause ‘signal amplification’ from their target RNAs. In fact, should miRNAs do so, the secondary siRNAs may cause unintended repression of genes homologous to miRNA targets.
However, for a small number of miRNAs and their targets, such ‘signal amplification’ occurs in plants. In fact, a widespread and deeply conserved phenomenon in diverse land plants is miRNA-triggered production of phased secondary siRNAs (phasiRNAs) from target transcripts (reviewed in [Fei et al., 2013]). Upon miRNA-guided cleavage of a target RNA, either the 5’ or 3’ cleavage fragment is converted by RdRP to double-stranded RNA, which is then successively diced into 21-nt phasiRNAs, with the phase determined by miRNA-guided cleavage (Allen et al., 2005; Axtell et al., 2006). In Arabidopsis, eight noncoding TAS loci generate phasiRNAs in this manner and, as the phasiRNAs regulate target genes in trans, they are termed trans-acting siRNAs (ta-siRNAs) (Allen et al., 2005; Axtell et al., 2006; Peragine et al., 2004; Rajagopalan et al., 2006; Vazquez et al., 2004b). Most miRNAs are 21 nt long and do not trigger phasiRNA production. A predominant mechanism (termed the ‘one hit model’) to trigger phasiRNA production is by a 22-nt miRNA (Chen et al., 2010; Cuperus et al., 2010); the TAS1, 2, and 4 loci are examples of the ‘one-hit’ model with 22-nt miR173 or miR828 as the trigger (Allen et al., 2005; Rajagopalan et al., 2006). In a ‘two-hit’ model, a pair of 21-nt miRNAs target the same transcript to cause phasiRNA production (Axtell et al., 2006). The three TAS3 loci are such examples, each containing two sites for miR390 (Axtell et al., 2006), a miRNA that associates with AGO7 instead of AGO1 to trigger phasiRNA production (Montgomery et al., 2008). In addition to the noncoding TAS loci, a small number of protein-coding genes in Arabidopsis such as immune receptor (NBS-LRR) and pentatricopeptide repeat (PPR) genes are targeted by 22-nt miRNAs and produce phasiRNAs (Chen et al., 2007; Howell et al., 2007).
Where phasiRNA biogenesis occurs in the cytoplasm is unknown. Intriguingly, SGS3 and RDR6, two proteins required for phasiRNA biogenesis (Peragine et al., 2004; Vazquez et al., 2004b), form cytoplasmic foci called siRNA bodies, which are often adjacent to vesicles marked by a cis-Golgi marker (Jouannet et al., 2012). In addition, both SGS3 and AGO7 are present in the microsomal fraction (Jouannet et al., 2012), implicating that ta-siRNA biogenesis occurs on a cytoplasmic membrane structure. A recent study found that TAS3 RNA is bound by ribosomes, and ribosomes on TAS3 RNA are stalled by AGO7 at the miR390-binding site, implicating that ta-siRNA biogenesis from TAS3 occurs on polysomes (Hou et al., 2016).
We combined genomic approaches with cellular fractionation to study the subcellular distribution of small RNAs and messenger RNAs (mRNAs). We found an intriguing difference between miRNAs and siRNAs in their membrane-cytosol partitioning. We showed that all miRNAs, including 22-nt miRNAs, were associated with membrane-bound polysomes (MBPs) as opposed to polysomes in general. The plant miRNA effector AGO1 associated with membranes in part in an RNA-independent manner, recruited miRNAs to membranes, and exerted its endonuclease activity on MBPs. Reduced membrane-association of 22-nt miRNAs in an ago1 mutant led to reduced levels, or loss of phasing, of phasiRNAs. The TAS transcripts, presumed to be noncoding, were actually bound by MBPs in a manner that supports phasiRNA production. These findings establish MBPs as the site of action of plant miRNAs and uncover a role of ribosomes and the ER in siRNA biogenesis, thus expanding the known functions of the rough ER.
Results
Differential partitioning of miRNAs and siRNAs between membranes and cytosol
We previously uncovered an integral ER membrane protein (named AMP1) as required for miRNA-mediated translational repression of target RNAs and showed that a few examined miRNAs and their target transcripts were present on MBPs (Li et al., 2013). To gain a global view of the membrane association of cellular small RNAs (sRNAs), we performed sRNA sequencing (sRNA-seq) for total (T) and microsomal (M; Figure 1A) RNAs. Three biological replicates were highly reproducible (Figure 1—figure supplement 1A). For an initial analysis, we quantified sRNAs by normalizing against total reads. The T sRNA population was characterized by two prominent size classes, 21 nt and 24 nt, as previously observed (Kasschau et al., 2007; Lu et al., 2006) (Figure 1—figure supplement 1B). In contrast, the M sRNA population exhibited a larger 21-nt peak and a diminished 24-nt peak (Figure 1—figure supplement 1B). In both T and M sRNA populations, miRNAs were the major component in the 21-nt class while P4siRNAs (Pol IV-dependent siRNAs) were a major component of the 24-nt class (Figure 1—figure supplement 1C). Notably, in the M fraction, the proportion of miRNAs was increased in 21-, 22-, and 24-nt classes (Figure 1—figure supplement 1C).
As the M fraction was a crude membrane preparation, and our previous study implicated the rough ER as the site of miRNA-mediated translational repression (Li et al., 2013), we sought to determine whether ER-associated sRNAs show a similar profile as M sRNAs. We took advantage of a transgenic line expressing an ER membrane protein SEC12 fused to YFP (YFP-SEC12) (Agee et al., 2010) to enrich for the ER. YFP-SEC12 was present in the M fraction as expected (Figure 1—figure supplement 1D), and the YFP tag was on the cytosolic side of the ER (Figure 1—figure supplement 1E). We pulled down ER using anti-YFP antibodies; western blotting showed that this ER preparation contained two ER proteins YFP-SEC12 and HSC70 but not ARF1 and SYP22, which marks Golgi and endosome, respectively (Ebine et al., 2008; Ritzenthaler et al., 2002) (Figure 1—figure supplement 1F). Similar to the M fraction, the ER preparation showed a skewed sRNA size distribution towards 21 nt (Figure 1—figure supplement 1B).
Because the M and T samples differed drastically in the composition of small RNAs, normalization against total reads were not appropriate if comparisons of sRNA levels between the two sample types were to be made. To establish a reasonable normalization method for such comparisons, we utilized published sRNA-seq libraries from wild type and the nrpd1-1 mutant (Li et al., 2015). NRPD1 encodes the largest subunit of Pol IV (Herr et al., 2005); the sRNA population in nrpd1-1 lacks most 24-nt P4siRNAs (Mosher et al., 2008; Zhang et al., 2007) (Figure 1—figure supplement 1H), which resembles the M sRNA profile (Figure 1—figure supplement 1B). Although miRNA abundance is unaffected in Pol IV mutants (Herr et al., 2005; Kanno et al., 2005; Onodera et al., 2005), miRNAs appeared to be greatly increased in abundance when read counts were normalized against total mapped reads (Figure 1—figure supplement 1I), and this was also true for 21-nt sRNAs (Figure 1—figure supplement 1H). We found that if normalization was performed against 18–41-nt rRNA fragments (from 5.8S, 18S, and 25S rRNAs from 80S ribosomes), then the levels of 21-nt sRNAs and miRNAs were similar in WT and nrpd1-1 (Figure 1—figure supplement 1J,K), which better reflected the actual situation. Thus, rRNA fragments could serve as an internal control in sRNA-seq quantification for our purposes. We refer to the normalized read counts as RPMR (reads per million rRNA fragments).
We re-analyzed T and M sRNA-seq using this normalization method, which was also used for all subsequent sRNA-seq analyses in this study. The size distribution of M sRNAs still showed a diminished 24-nt peak and an increased 21-nt peak (Figure 1B), indicating not only a depletion of 24-nt sRNAs but also an increase in 21-nt sRNAs in the M fraction. The M fraction had a higher proportion of miRNAs for 21-, 22-, and 24-nt size classes than the T samples (Figure 1C), indicating that miRNAs were enriched in the membrane fraction relative to other small RNAs.
The reduction in the 24-nt peak in the M fraction was due to a depletion of P4siRNAs. The Arabidopsis genome was divided into consecutive and non-overlapping 100 bp windows, and normalized sRNA read counts in each window were compared between M and T samples. P4siRNA read counts were much lower in the M fraction (Figure 1—figure supplement 1G). Note that the great majority of P4siRNAs reside in the cytoplasm, despite their nuclear functions in guiding DNA methylation (Ye et al., 2012). Therefore, most cytoplasmic P4siRNAs were not associated with membranes. Thus, this work revealed an intriguing difference in the partitioning between membranes and cytosol for miRNAs and P4siRNAs.
Association of miRNAs with membrane-bound polysomes (MBPs)
Having shown that miRNAs were enriched in the M fraction relative to P4siRNAs and other siRNAs, we next asked whether they were present on MBPs. We isolated MBPs (diagrammed in Figure 1A and in more detail in Figure 1—figure supplement 2A; a representative MBP profile is shown in Figure 1—figure supplement 2A) in three biological replicates and performed sRNA-seq (reproducibility is shown in Figure 1—figure supplement 1A). MBP-associated sRNAs had a profile with a large 21-nt peak and a small 24-nt peak (Figure 1D). The proportions of miRNAs in all size classes were higher in MBP than in T (Figure 1C), suggesting that miRNAs were enriched in MBP relative to other sRNAs.
AGO1 co-fractionates with polysomes (Lanet et al., 2009), implying that miRNAs associate with polysomes. Thus, the observed MBP enrichment of miRNAs could be attributed to the association of miRNAs with polysomes in general. To determine whether miRNAs associated with MBPs, a more meaningful comparison would be between MBPs and total cellular polysomes (TPs). We isolated TPs (diagrammed in Figure 1—figure supplement 2B) and MBPs from the same seedling samples in three biological replicates and sequenced the associated sRNAs (reproducibility is shown in Figure 1—figure supplement 1A). The MBP samples had a much larger 21-nt peak relative to TP samples (Figure 1D), indicating that the enrichment of 21-nt sRNAs in MBP was due to their association with MBPs but not polysomes in general. For each size class, and particularly for the 22-nt class, the proportion of miRNAs was greatly increased in MBP relative to TP (Figure 1C).
The abundance of individual miRNAs in MBP and TP fractions was determined using reads that mapped exactly to annotated miRNAs or miRNA*s. Most miRNAs as well as some detectable miRNA*s showed higher abundance in MBP vs. TP (Figure 1E). 21-nt and 22-nt ta-siRNAs (from TAS1 to TAS4 loci) also had higher levels in MBP (Figure 1F). To evaluate the MBP enrichment of miRNAs and ta-siRNAs relative to other 21-nt or 22-nt sRNAs, we calculated 21-nt or 22-nt sRNA counts in 100 bp windows of the genome. Endogenous siRNAs constituted most of the 21-nt or 22-nt sRNA-generating regions of the genome. Only a small set of the windows produced MBP-enriched sRNAs (green circles in Figure 1G,H), suggesting that a small set of endogenous siRNAs was enriched on MBPs while the majority of siRNAs were not.
To identify MBP-enriched sRNAs, we compared the abundance of sRNAs in each 100 bp window for each sRNA size class (21, 22, 23, and 24 nt) between MBP and TP samples. This analysis revealed higher numbers of hyper (MBP>TP) than hypo (MBP<TP) differential sRNA regions (DSRs) (Figure 1—figure supplement 2C, Supplementary file 1). At the 21-nt and 22-nt hyper DSRs, 25–50% overlapped with MIR and TAS genes (Figure 1—figure supplement 2D).
The large number of 22-nt hyper DSRs was particularly intriguing, as 22-nt sRNAs have the unique capacity to trigger the biogenesis of phasiRNAs from their target genes. Among the 188 22-nt hyper DSRs, 31 overlapped with MIR genes representing 24 miR families (Supplementary file 1). This was surprising, as only a few miRNAs are annotated as 22 nt long. This prompted us to interrogate the sizes of all Arabidopsis miRNAs using our sRNA-seq datasets.
Among a total of 427 Arabidopsis miRNAs, 178 were at an average level > 1 RPMR in the 12 sRNA-seq samples (three samples each for T, M, MBP and TP from wild type) (Supplementary file 2). Of these 178 miRNAs, 141 and 17 were annotated as 21 nt and 22 nt, respectively (Supplementary file 2). By examining the actual sizes of the miRNAs, we found that many miRNAs had both 21-nt and 22-nt isoforms, and the annotated size represented the size of the major isoform (Figure 2A). 22-nt miRNAs, regardless of whether they were the major or minor isoforms, were more abundant in MBP relative to TP (Figure 2B).
We investigated how the 22-nt miRNA isoforms from predominantly 21-nt miRNA-producing loci arose. The 22-nt miRNA isoforms tended to have a genome-matched 1-nt extension relative to the 21-nt major isoforms, and 3’ extension was more prevalent than 5’ extension (Figure 2C). DCL1 is the Dicer that generates miRNAs, most of which are 21 nt long (Park et al., 2002; Reinhart et al., 2002), and DCL2 produces 22-nt siRNAs (Gasciolli et al., 2005). The abundance of 22-nt miRNA isoforms was greatly reduced in a dcl1 mutant but not in a dcl2 mutant (Figure 2D) (Kasschau et al., 2007), suggesting that the 22-nt miRNA isoforms were made by DCL1. Thus, precursor processing by DCL1 is not precise such that 22-nt miRNA isoforms from many MIR genes are made. This poses a potential problem, as 22-nt miRNA isoforms have the potential to trigger phasiRNA production from target transcripts.
The MBP-associated transcriptome
Given that miRNAs were enriched in the MBP fraction, we asked whether they could meet their target transcripts on MBPs. The canonical view is that transcripts encoding proteins that enter the secretary pathway are co-translationally recruited to the ER. Under such a scenario, many miRNA target transcripts, which encode transcription factors, are not expected to be on MBPs. However, we found that a few miRNA target transcripts were present on MBPs (Li et al., 2013). To gain a global view of MBP-associated mRNAs, we performed polyA+ RNA-seq of MBP RNAs and total RNAs. We found that the overall profiles of MBP and total RNAs were highly similar (data not shown), suggesting that all cellular mRNAs were represented on MBPs.
To further validate this, we switched to another method of fractionation that allowed for the simultaneous recovery of MBPs and cytosolic free polysomes (FPs) (Figure 3—figure supplement 1). Note that this purification scheme could not result in MBPs as pure as the previous method (Figure 1—figure supplement 2A), but was used here to allow the comparison between MBP and FP RNAs. In brief, total extracts were first separated into microsome and cytosol fractions, from which MBPs and FPs were then isolated, respectively. The MBP and FP profiles on sucrose gradients were as expected (Figure 3—figure supplement 1A). The microsome, cytosol, MBP, and FP RNAs were then subjected to polyA+ RNA-seq in three biological replicates (reproducibility is shown in Figure 3—figure supplement 1B). Clustering analysis using the 5000 top varying transcripts (Supplementary file 3.1) showed that the microsome and MBP fractions clustered together and the cytosol and FP fractions clustered together (Figure 3A). This indicated that the separation of these fractions was successful. We next examined transcripts encoding transmembrane domain-containing proteins; these transcripts were expected to be translated on MBPs (Supplementary file 3.2). Indeed, many of these transcripts showed higher abundance in microsome than cytosol (green circles in Figure 3B) and in MBP than FP (green circles in Figure 3C). This further validated the successful fractionation. Most cellular transcripts were similarly represented on MBPs and FPs, with a large fraction over-accumulated on MBPs (Figure 3D). Likewise, the majority of predicted and known targets of miRNAs (Supplementary file 3.3) were equally represented on MBPs and FPs, with few being depleted from MBPs (Figure 3E). This suggested that nearly all cellular transcripts are translated on MBPs as well as FPs.
RNA-independent membrane association of AGO1
AGO1 partially co-localizes with ER and co-fractionates with microsomes and MBPs (Brodersen et al., 2012; Li et al., 2013). We examined M and MBP fractions for the presence of AGO1 and AGO4 by western blotting. As expected, AGO1 was found in both M and MBP fractions (Figure 4A). AGO4, which binds most 24-nt P4siRNAs (Qi et al., 2006), was not detected in either fraction (Figure 4A), which is consistent with the observed depletion of P4siRNAs from these fractions (Figure 1—figure supplement 1G).
To determine whether AGO1’s membrane association relied on miRNAs, we isolated microsomes from mutants in miRNA biogenesis genes DCL1 and HYL1 (Han et al., 2004; Park et al., 2002; Reinhart et al., 2002; Vazquez et al., 2004a). Microsomal AGO1 levels were unaffected in these mutants (Figure 4B; Figure 4—figure supplement 1), suggesting that AGO1’s membrane association was most likely miRNA-independent. To determine whether AGO1’s membrane association relied on long RNAs, we treated total cell extracts with RNase I followed by microsome isolation. Full-length CSD2 RNA (a target of miR398) was eliminated by RNase I treatment (Figure 4C). AGO1, miR398, and miR156 were still present in the M fraction (Figure 4C,D), although their levels were reduced. Therefore, AGO1’s membrane association was largely independent of intact target RNAs.
To investigate whether AGO1’s MBP association was RNA-dependent, we first isolated MBPs and then fractionated MBPs by sucrose gradient centrifugation to separate the light fraction containing ribosomal subunits and 80S monosomes from the polysomes (Figure 4E; right panel). AGO1 was found in both the light fraction and the polysomes (Figure 4E; bottom panel). We digested MBPs with RNase I; the sucrose gradient profiles of the digested MBPs showed that the polysomes were reduced to monosomes (Figure 4E; left panel). AGO1 was still detectable in this monosome fraction but at much reduced levels (Figure 4E; bottom panel). This showed that AGO1’ MBP-association depended to a large extent on intact mRNAs.
AGO1-dependent membrane association of miRNAs
Having shown that AGO1’s membrane association was largely independent of miRNAs or mRNAs, we next sought to determine whether miRNAs’ membrane association depended on AGO1. If AGO1 recruits miRNAs to the ER, then the levels of microsomal miRNAs should be reduced in ago1 mutants. We first examined the ago1-36 mutant that lacks a full-length AGO1 protein and exhibits severe morphological defects (Baumberger and Baulcombe, 2005) (Figure 5A). Despite a global reduction in miRNA accumulation in this mutant (Vaucheret et al., 2004), a few miRNAs accumulated to levels similar to wild type (Figure 5A), presumably because these miRNAs associated with other AGOs or non-AGO proteins. The levels of these miRNAs in microsomes were reduced in ago1-36 (Figure 5A), suggesting that AGO1 promoted the membrane association of these miRNAs.
In order to obtain a global view of the membrane association of miRNAs in an ago mutant, we resorted to the weaker ago1-27 allele from which sufficient plant material could be obtained. Three biological replicates of sRNA-seq were performed for total extracts (T) and two for the microsomal fraction (M) in this mutant (Figure 1—figure supplement 1A). Consistent with previous observations (Vaucheret et al., 2004), the ago1-27 mutation did not have a strong overall effect on miRNA accumulation (Figure 5B). The membrane association of miRNAs, represented by the M/T ratio, was drastically reduced in ago1-27 for most miRNAs (Figure 5C), suggesting that the membrane association of miRNAs depended on AGO1. In this analysis, miR390 was an internal control - it is bound by AGO7 (Montgomery et al., 2008) and thus its membrane association should not be affected by the ago1-27 mutation. The M/T ratio of miR390 was largely unchanged in ago1-27 (Figure 5C). The M/T ratio was also reduced for most 21–22-nt ta-siRNAs (from TAS1 to TAS4 loci) in ago1-27 (Figure 5D). As ta-siRNAs are bound by AGO1 (Baumberger and Baulcombe, 2005), this also supports the conclusion that AGO1 recruits sRNAs to membranes.
miRNA-guided cleavage in M and MBP fractions
The subcellular location of miRNA-guided target RNA cleavage has been unknown and perhaps presumed to be in the cytosol. We investigated whether miRNA-guided cleavage was detectable in the M fraction. AGO1 was immunopecipitated from total extracts and from microsomes, and slicer assay was carried out by incubating AGO1 immunoprecipitates with radiolabeled PHB RNA containing the miR165/6-binding site. This RNA was cleaved by AGO1 immunoprecipitates from both total extracts and microsomes (Figure 6A).
3’ cleavage fragments can be detected in vivo by 5’ RACE RT-PCR (Llave et al., 2002). We searched for 3’ cleavage fragments from M and MBP RNAs by 5’ RACE RT-PCR. Cloning and sequencing of the 3’ cleavage fragments from a few miRNA target genes showed that cleavage occurred precisely at the expected positions for both M and MBP RNAs (Figure 6B,C).
phasiRNA production from miRNA target transcripts on MBPs
The finding of miRNA-guided cleavage occurring on MBPs prompted us to study the relationship between the MBP association and the phasiRNA-triggering activity of miRNAs. We focused on small RNAs known to cause phasiRNA production from their target transcripts. These were miR161.1 targeting PPR genes, miR168 targeting AGO1, miR173 targeting TAS1 and TAS2, miR393 targeting auxin receptor genes (AFB2 and AFB3), miR472 and miR825* targeting NBS-LRR genes, and miR828 targeting TAS4. Among these miRNAs, miR173, miR393 and miR828 are predominantly 22 nt long while the others are predominantly 21 nt long with 22-nt isoforms. We also identified two new phasiRNA-generating loci: CIL2 (At3g23690) encoding a basic helix-loop-helix protein and being targeted by miR393, and At5g43740 encoding an NBS-LRR protein and being targeted by miR472 (Figure 7—figure supplement 1A). As a control, we also included miR390, which is 21 nt long, bound by AGO7, and triggers ta-siRNA production from TAS3 loci in a ‘two hit’ mode. In addition, ta-siR2140 is a ta-siRNA from TAS2; this ta-siRNA is 22 nt long and able to trigger phasiRNA production from a PPR gene (Chen et al., 2007).
The levels of these sRNAs were unaffected or mildly reduced in ago1-27 in total extracts (Figure 7A; top panel). However, the abundance of these sRNAs in microsomes was much lower in ago1-27, indicating that these sRNAs associated with membranes in an AGO1-dependent manner (Figure 7A; top panel). As expected, neither the overall nor the microsomal abundance of miR390 was reduced in ago1-27 (Figure 7A; lower panel).
Levels of phasiRNAs were determined by sRNA-seq in ago1-27, ago1-36, and wild type. As expected, phasiRNAs from all 23 examined loci (Supplementary file 4; TAS3 loci excluded) were nearly eliminated in ago1-36 (Figure 7B, Figure 7—figure supplement 1B). For 21 of the 23 phasiRNA loci examined, the overall abundance of siRNAs was significantly reduced in ago1-27 (Figure 7B, Figure 7—figure supplement 1B, Supplementary file 4). In ago1-27, the siRNAs from AGO1 RNA were similar in abundance to wild type, but the phasing triggered by miR168-guided cleavage was nearly lost (Figure 7C). Notably, miR168 was one of the most affected miRNAs in terms of membrane association in ago1-27 (Figure 5C). As a control, the abundance of TAS3 ta-siRNAs (triggered by miR390-AGO7) was not reduced (they were in fact increased) in ago1-27 (Figure 7B). The phasing of TAS3 ta-siRNAs was unaffected (Figure 7—figure supplement 1C). Therefore, the reduction in phasiRNAs levels from non-TAS3 loci in ago1-27 was not due to inability of the AGO1-27 protein to bind phasiRNAs. The AGO1-27 protein was still associated with miRNAs, as shown by AGO1 IP followed by northern blotting to detect miRNAs (Figure 6D). The AGO1-27 protein was still capable of miRNA-guided cleavage in an in vitro slicer assay (Figure 6E), consistent with the previous conclusion that the ago1-27 allele is normal in miRNA-guided cleavage in vivo (Brodersen et al., 2008). Thus, reduced phasiRNA abundance, or loss of phasing, coincided with decreased membrane association of the triggering miRNAs in ago1-27. These data, together with the finding that miRNA-guided cleavage occurs in M and MBP fractions, suggested that phasiRNA production occurs, or at least starts, on MBPs. This is also consistent with the reported membrane association of ta-siRNA biogenesis factors (Jouannet et al., 2012).
If phasiRNA biogenesis occurs on MBPs, we expect to detect the above-mentioned miRNA target transcripts on MBPs. We performed ribosome-protected fragment sequencing (ribo-seq) with MBPs. In brief, MBPs were first isolated (Figure 1—figure supplement 2A) and then treated with RNase I to resolve polysomes to monosomes. The monosomes were recovered from sucrose gradient centrifugation (as in Figure 4E), and monosome-protected RNA fragments were subjected to high-throughput sequencing. Regular RNA-seq was also performed with MBP RNAs. Our ribo-seq was successful as reflected by the fact that reads were derived predominantly from coding regions and regions close to the start and stop codons in UTRs, whereas MBP RNA-seq reads covered entire transcripts (Figure 8A). All above-mentioned, phasiRNA-generating, protein-coding genes were indeed present on MBPs (Figure 8B and data not shown).
Most importantly, we found that the TAS transcripts, which were thought to be non-protein-coding, were associated with MBPs. Although the entire TAS transcripts were associated with MBPs, as revealed by RNA-seq of MBP RNAs (Figure 8C), there was a sharp boundary between ribosome-protected and non-protected portions of each TAS transcript (Figure 8C). The ribosome-protected portions corresponded to the short open reading frames (ORFs) present in these RNAs. Amazingly, the miRNA-binding site was at the boundary of ribosome-protected and non-protected portions in each TAS transcript (Figure 8C), and the region unbound by ribosomes generated ta-siRNAs (compare sRNA-seq reads with ribo-seq reads in Figure 8C). An earlier study showed that the miRNA-binding site needs to be close to the upstream stop codon for phasiRNA biogenesis from an artificial phasiRNA-generating locus (Zhang et al., 2012). These observations suggest that the initial triggering step (i.e. miRNA-guided cleavage) in phasiRNA biogenesis occurs on MBPs and ribosome occupancy plays a role in specifying which transcript or portion of a transcript undergoes phasiRNA biogenesis.
Discussion
Previously, we found that the integral ER membrane protein AMP1 is required for the translational repression activity of plant miRNAs, suggesting that the rough ER is the site of miRNA-mediated translational repression (Li et al., 2013). A few miRNAs and their target transcripts were found to be associated with MBPs (Li et al., 2013), but the scale of the MBP-association of miRNAs and their target transcripts was unknown. In this study, we examined the ER- and rough ER-association of small RNAs as well as cellular mRNAs. We found that most cellular mRNAs were enriched on MBPs or equally partitioned between MBPs and FPs. This indicates that most mRNAs, including miRNA target transcripts, are translated both on the rough ER and in the cytosol. AGO1 was previously shown to associate with polysomes, thus implicating the presence of miRNAs on polysomes. In this study, we found that miRNAs are associated with MBPs rather than polysomes in general.
AMP1 is only required for the translational repression activity of plant miRNAs, thus it was not known whether miRNA-guided cleavage occurs on MBPs. In this study, we found that miRNA-guided cleavage does occur on MBPs. However, it should be noted that our findings do not exclude the occurrence of miRNA-guided cleavage in the cytosol. Our studies with the null allele ago1-36 and the weak allele ago1-27 showed that AGO1 is instrumental in recruiting miRNAs to the ER. But it is not known how the weak ago1-27 mutant compromises the membrane association of miRNAs, as the mutant protein was still membrane- and MBP-associated (Figure 4A–B).
We found that phasiRNA production from most known phasiRNA-generating loci was reduced in ago1-27, in which the triggering miRNAs showed reduced membrane association. The TAS transcripts, despite not having long open reading frames, were present on MBPs and were bound by ribosomes in a manner that ‘exposed’ the ta-siRNA-generating portions. These findings indicate that phasiRNA production occurs, or is at least initiated, on MBPs. This is consistent with the finding that phasiRNA biogenesis factors reside in siRNA bodies that are in close proximity to a cis-Golgi marker (Jouannet et al., 2012). A recent study showed that TAS3 RNA is bound by ribosomes, and AGO7 causes ribosome stalling upstream of the miR390 binding site (Hou et al., 2016). Our study confirms the ribosome association of TAS3 RNA, extends the observation of ribosome occupancy to other TAS RNAs, and reveals the association of TAS RNAs with MBPs.
However, we do not believe that MBPs offer an optimal environment for phasiRNA production. We found that many MIR genes produce 22-nt isoforms due to imprecision in DCL1 processing, yet most 22-nt miRNA isoforms do not trigger phasiRNA production from their target RNAs. We propose that the sequestration of 22-nt miRNAs and miRNA target transcripts on MBPs prevents them from engaging in phasiRNA production. We propose that the rough ER is somehow capable of inhibiting the entry of most protein-coding transcripts into the phasiRNA biogenesis pathway. The TAS genes and a handful of protein-coding genes have evolutionarily adapted to the rough ER environment by having an optimal arrangement between the miRNA binding site and ribosome occupancy to enable phasiRNA biogenesis. Thus, ER and ribosomes have a previously unknown function in regulating the biogenesis of small RNAs.
Materials and methods
Plant materials
Request a detailed protocolArabidopsis thaliana (RRID:SCR_004618) wild-type (Columbia accession), ago1-27 (Vaucheret et al., 2004), hyl1-2 (Han et al., 2004; Vazquez et al., 2004a), and SUC2:amiR-SUL (de Felippes et al., 2011) strains were used in this study.
Microsome and MBP isolation
View detailed protocolThe isolation of microsomes and MBPs for small RNA sequencing was performed as described (Li et al., 2013). In brief, 2 g of seedlings were ground in 7 ml microsome isolation buffer (MEB: 100 mM Tris-HCl, pH7.5, 5 mM EGTA, 15 mM MgCl2, 5 mM DTT, 0.3M sucrose, 50 U/ml superaseIN (Invitrogen, Thermo Fisher Scientific, Waltham, MA, USA), 50 μg/ml cycloheximide, 50 μg/ml chloramphenicol, and a complete proteinase inhibitor cocktail (Roche)), and the cell lysate was filtered by 2 layers of miracloth and centrifuged at 10,000 g twice to remove debris. A 100 µl aliquot was taken from the clarified supernatant as input, and the rest was applied onto a sucrose step gradient (2.5 ml 20%/2.5 ml 60% sucrose), and centrifuged at 100,000 g in an SW41 rotor (Beckman coulter) for 1 hr. Microsomes were recovered from the interface of the two sucrose layers, diluted with 10 volumes of MEB and precipitated by centrifugation at 100,000 g for 30 min.
To isolate MBP, the microsome preparation was lysed with 8 ml polysome isolation buffer (0.2M Tris-HCl, pH9.0, 0.2M KCl, 0.025M EGTA, 0.035M MgCl2, 0.2% Brij-35, 0.2% Triton X-100, 0.2% Igepal CA630, 0.2% Tween 20, 0.2% polyoxyethylene 10 tridecyl ether, 5 mM DTT, 1 mM PMSF, 50 μg/ml cycloheximide, 50 μg/ml chloramphenicol and 2.5 U/ml superaseIN). The lysate was kept on ice for 30 min, and then loaded on the top of a sucrose cushion (0.4M Tris-HCL, pH9.0, 0.2M KCl, 0.005M EGTA, 0.035m MgCl2, 1.75M sucrose, 5 mM DTT, 50 μg/ml cycloheximide, and 50 μg/ml chloramphenicol) and centrifuged at 170,000 g for 3 hr. The pellet was dissolved with resuspension buffer (0.2M Tris-HCl, pH9.0, 0.2M KCl, 0.025M EGTA, 0.035M MgCl2, 5 mM DTT, 50 μg/ml cycloheximide, and 50 μg/ml chloramphenicol) and the solution was transferred into a new tube as the MBP fraction. An aliquot of the MBP was subjected to 15–50% sucrose gradient centrifugation for polysome integrity evaluation, and the rest was used for sRNA and mRNA sequencing.
Isolation of cytosol, microsome, free polysomes (FPs) and membrane-bound polysomes (MBPs)
Request a detailed protocolThe simultaneous recovery of cytosol and microsomal fractions from the same samples, followed by the isolation of FPs and MBPs from the two fractions, respectively, was performed according to (de Jong et al., 2006). Briefly, 2 g of seedlings were ground in liquid nitrogen, and the powder was resuspended with 8 ml extraction buffer (0.2M Tris-HCl, pH8.5, 0.1M KCl, 70 mM Mg(C2H3O2)2, 50 mM EGTA, 0.25M sucrose, 10 mM DTT, 50 ug/ml cycloheximide, 50 ug/ml chloramphenicol and 2.5 U/ml superaseIN). The slurry was filtered by 2 layers of miracloth and centrifuged twice at 10,000 g for 10 min to remove debris. Microsomes were pelleted by centrifugation at 30,000 g for 30 min in a Beckman SW28 rotor. The supernatant was transferred into a new tube as the cytosol fraction, and the microsome pellet was dissolved with 8 ml extraction buffer supplemented with 1% v/v Triton X-100. Both the cytosol and microsomal fractions were centrifuged again at 30,000 g for 30 min to remove any residual membranes, and the supernatant was loaded onto an 8 ml 1.75M sucrose cushion as described in the 'Microsome and MBP isolation' section and centrifuged at 170,000 g for 3 hr. The FP and MBP pellets were resuspended with 400 µl resuspension buffer as described in the 'Microsome and MBP isolation' section, and polysome integrity evaluation was conducted as before.
Note that this procedure does not recover MBPs that are as pure as the procedure described above, but allows the simultaneous recovery of both cytosol and microsomes. This MBP isolation approach was only used when FP and MBP transcriptomes were compared. RNA was extracted from the cytosol and microsomal fractions by TRI-reagent (Molecular Research Center) and subjected to RNA-seq (see below).
Isolation of total polysomes (TPs)
Request a detailed protocolTotal cellular polysomes were isolated as previously described (Mustroph et al., 2009). Briefly, 1g seedlings were ground in liquid nitrogen and the powder was resuspended in 8 ml polysome extraction buffer (see the 'Microsome and MBP isolation' section). The slurry was clarified by centrifugation at 10,000 g for 10 min at 4°C twice. The supernatant was loaded onto an 8 ml 1.75M sucrose cushion, and ribosomes were pelleted at 170,000 g for 3 hr at 4°C in a Type70 Ti rotor (Beckman Coulter) and resuspended in 400 µl resuspension buffer (see the 'Microsome and MBP isolation' section) for RNA isolation and analysis of polysome profiles.
Determination of AGO1 levels in microsomal and MBP fractions
Request a detailed protocol1.5 g seedlings were ground in liquid nitrogen and the powder was resuspended in 4 ml MEB buffer. The slurry was clarified by passage through two layers of miracloth and centrifugation at 10,000 g for 10 min twice at 4°C. The supernatant was subjected to further centrifugation at 100,000 g for 1 hr at 4°C to separate the cytosol (the soluble) and microsomal (the pellet) fractions. The pellet was washed by the same amount of MEB once again to avoid cytosol contamination of the microsomal fraction.
AGO1 and AGO4 were detected by western blotting with anti-AGO1 or anti-AGO4 antibodies (AGO1: AgriSera Cat# AS09 527 RRID:AB_2224930; AGO4: AgriSera Cat# AS09 617 RRID:AB_10507623). To test the RNA dependence for AGO1’s membrane association, the clarified plant extract was treated with either RNase inhibitor (as a control) or 80 units/ml RNase I at room temperature for 1 hr, after which microsomes were isolated and subjected to RNA and protein analyses as described above.
To detect AGO1’s association with MBPs, MBPs were isolated as described in the ‘Microsome and MBP isolation’ section, and subjected to sucrose gradient centrifugation to separate the light fraction containing the 40S, 60S, and 80S ribosomes from the polysomes. Proteins were isolated from these fractions using TRI reagent (Molecular Research Center) following manufacturer's instructions. To determine the RNA-dependence of AGO1’s MBP association, 1000 O.D.260 units of MBPs were treated with 1500 units of RNase I followed by sucrose gradient centrifugation. The light fraction containing the 40S, 60S, and 80S ribosomes and the heavy fraction containing polysomes were recovered. Proteins were isolated from these fractions with TRI reagent following manufacturer's instructions and subjected to western blotting to detect AGO1 and the ribosomal protein L13 with commercial antibodies (AgriSera Cat# AS09 478 RRID:AB_2060757).
ER immunoprecipitation
Request a detailed protocol1 g seedlings expressing YFP-SEC12 were ground in liquid nitrogen into fine powder, and the powder was resuspended with 2 ml IP buffer containing 50 mM Tris-HCl (pH7.5), 150 mM NaCl, 0.3M sucrose, 10% glycerol, and 1x proteinase inhibitor (Roche). 100 µl supernatant was saved as the input after clarification by 10,000 g centrifugation at 4°C, and the rest was used for immunoprecipitation. Briefly, the extract was pre-cleared by Dynabeads (Invitrogen), incubated with anti-GFP antibodies (Clontech Laboratories, Inc. Cat# 632592 RRID:AB_2336883) for 2 hr at 4°C with gentle rotation, and washed by IP buffer four times. The beads were boiled with 1x protein loading buffer, and the proteins were subjected to western blotting to detect YFP-SEC12, HSC70, ARF1, SYP22, and PEPC using commercial antibodies (anti-GFP: Clontech Laboratories, Inc. Cat# 632380 RRID:AB_10013427; anti-HSC70: Enzo Life Sciences Cat# ADI-SPA-818-F RRID:AB_11180122; anti-ARF1: AgriSera Cat# AS08 325 RRID:AB_1271007; anti-SYP22: a gift from Dr. Natasha Raikhel; PEPC: AgriSera Cat# AS09 458 RRID:AB_2063166). Using the same procedure, ER IP was performed followed by RNA isolation and sRNA sequencing (see below for sRNA library construction and data analysis).
Membrane topology analysis for the YFP-SEC12 protein
Request a detailed protocolMicrosomes from YFP-SEC12 transgenic plants were isolated, resuspended with MEB buffer, and digested with 10 ng/µl proteinase K (Fermentas) in the presence or absence of 1% Triton X-100 for 20 min on ice. The reactions were stopped by the addition of phenylmethylsulfonyl fluoride to a final concentration of 5 mM and subjected to western blotting using anti-GFP antibodies (Clontech Laboratories, Inc. Cat# 632380 RRID:AB_10013427) to detect YFP-SEC12.
AGO1 immunoprecipitation (IP) and slicer assay
Request a detailed protocolTo IP AGO1 from total cell extracts, the same procedure as that of YFP-SEC12 IP was applied except that AGO1 antibody (AgriSera Cat# AS09 527 RRID:AB_2224930) was used. To IP AGO1 from microsomes, microsomes were first isolated and dissolved in IP buffer containing 1% of Triton X-100. The microsome lysate was then diluted by 10 volumes of non-detergent-containing IP buffer to reduce the Triton X-100 concentration to 0.1%, and immunoprecipitation was performed. After washes, the beads were resuspended in the reaction buffer for slicer activity assay (see below).
For the slicer activity assay, part of the PHB gene spanning the miR165/6 binding site was amplified with primers PHB-T7-F and PHB-R (Supplementary file 5). In vitro transcription was carried out with T7 RNA polymerase (Promega) in the presence of 32P UTP. The reaction mix was resolved on 5% polyacrylamide/7M urea gel. The band corresponding to the expected PHB transcript was excised from the gel, and the RNA was recovered by soaking the gel slicer in 0.3M NaCl overnight followed by precipitation with ethanol. The beads containing AGO1 immunoprecipitates were mixed with the PHB transcript in reaction buffer (1 mM ATP, 0.2 mM GTP, 1.2 mM MgCl2, 25 mM creatine phosphate, 30 mg/mL creatine kinase and 0.4 unit/mL RNase Inhibitor (Promega)). The reaction mix was incubated at room temperature for 2 hr. RNA was then extracted with TRI-reagent and resolved in a 5% polyacrylamide/7M urea gel, and 32P signals were detected with a Phosphoimager.
Detection of 3’ cleavage products in vivo
Request a detailed protocolTo detect the 3' cleavage products from miRNA targets, 5' RACE was performed using the GeneRacer kit (Invitrogen). Total RNAs were directly ligated with the GeneRacer RNA oligonucleotide and reverse transcription reactions were carried out with an oligo dT primer. Seminal quantitative PCR was performed with gene specific primers (Supplementary file 5) to quantify 3' cleavage products from miRNA targets. To map the cleavage position, the PCR products were cloned into the T-easy vector (Promega) and subjected to Sanger sequencing.
Small RNA library construction
Request a detailed protocol30 µg of RNA was resolved on 15% urea-PAGE gel, and the 18–30-nt region was excised from the gel. Small RNAs were recovered by soaking the smashed gel in 0.3M NaCl overnight, followed by precipitation with ethanol. Small RNA libraries were constructed following instructions from the Illumina Truseq small RNA library preparation kit (Illumina). The libraries were sequenced on an Illumina Hiseq 2500 at the UC Riverside Genomics core facility.
RNA-seq library construction
Request a detailed protocolRNA-seq libraries were constructed using the NEBNext mRNA Library Prep kit (NEB). Briefly, polyA+ RNAs were isolated with the Dynabeads mRNA DIRECT Purification Kit (ThermoFisher Scientific), and fragmented to approximately 200 nt. cDNA was synthesized with random primers, and DNA adaptors were ligated to both ends of the double-stranded cDNAs. PCR was performed with primers complementary to the sequences in the DNA adaptors to generate RNA-seq libraries, which were sequenced on Illumina Hiseq2500.
Analysis of sRNA-seq
Request a detailed protocolReads from Illumina sRNA-seq were first processed to remove the 3' adaptor sequences (TGGAATTCT or AGATCGGAA) and then size-selected (18 to 42 nt) using cutadapt v1.9.1 (Martin, 2011). Adaptor-free reads that aligned to rRNA/tRNA/snoRNA regions were then removed using Bowtie v1.1.0 (Langmead et al., 2009) with the parameters '-v 2 k1', and reads that were assigned to the 45S rRNA regions were counted. The rest of the reads were mapped to the TAIR10 genome (http://www.arabidopsis.org) using ShortStack v3.4 (Johnson et al., 2016) with parameters ' --bowtie_m 1000 --ranmax 50 --mmap u --mismatches 0 '. To calculate and compare small RNA abundance in different genotypes or samples, the genome was tiled into 100 bp windows and reads whose 5' end nucleotides fall within a window were assigned to the window. Normalization was performed by calculating the RPMR value (reads per million of 45S rRNA reads) for each window, and comparison was conducted by the R package 'DESeq2' (Love et al., 2014).
Annotated miRNA sequences were obtained from miRBase v21. To quantify miRNA abundance, adaptor-free reads were searched for those that matched to the sequence of each miRNA allowing for a 1-nt shift on either the 5’ or 3’ end. To quantify ta-siRNA levels, reads located within each of the eight annotated TAS gene regions (TAS1a, 1b, 1c, TAS2, TAS3a, 3b, 3c, and TAS4) were counted and summed separately for each size class (21 nt, 22 nt, 23 nt, and 24 nt). Windows that harbor P4siRNAs were determined as described (Li et al., 2015).
Small RNA phasing analysis
Request a detailed protocolPhasing analysis was performed as previously described (De Paoli et al., 2009; Howell et al., 2007). Small RNA reads from sense and antisense strands were unified. Phasing score was calculated by the following formula.
Where n = number of phase cycle positions occupied by ≥1 reads within a 10-cycle window. P = total number of reads for all sRNAs with start coordinates in a given phase within a 10-cycle window. U = total number of reads for all sRNAs with start coordinates outside of a given phase.
Processing and mapping of mRNA-seq reads
Request a detailed protocolRaw RNA-seq reads that passed the Illumina quality control steps were collapsed into a set of non-redundant reads. These non-redundant reads were mapped to the TAIR10 Arabidopsis genome using TopHat v2.0.4 with default settings (Kim et al., 2013). Reads that were mapped to multiple positions were excluded from further analyses. Cuffdiff (Trapnell et al., 2012) was used to calculate normalized gene expression levels and call differentially expressed genes (with FDR < 0.05 and fold change > 2).
Ribo-seq library construction
Request a detailed protocolA total of 2000 O.D.260 units of MBP was digested by 3000 units of RNase I (Ambion) in 400 µl digestion buffer (20 mM Tris-HCl, pH 8.0, 140 mM KCl, 5 mM MgCl2, 50 µg/ml cycloheximide, 50 µg/ml chloramphenicol) with gentle shaking at room temperature for 1.5 hr, and the digestion product was centrifuged in a 15–50% sucrose density gradient at 300,000 g for 1.5 hr. A gradient fractionation system (ISCO) was used to collect the monosome fraction. Monosomal RNAs were extracted with TRI Reagent (MRC), and resolved on 15% Urea-PAGE. RNAs corresponding to 25–35 nt were recovered from the gel and phosphorylated by T4 polynucleotide kinase (NEB). Next, the monosomal RNAs were further polyadenylated with PolyA Polymerase (NEB), and reverse transcribed with the primer oligodT linkerM (Supplementary file 5), followed by cDNA circularization with CircLigase (EpiCenter). rRNAs were removed by hybridization with biotin conjugated DNA probes (Supplementary file 5) followed by capture with Dynabead M-280 Streptavidin (Invitrogen). Finally, the Ribo-seq library was obtained by PCR with primers listed in Supplementary file 5.
Ribo-seq analysis
Request a detailed protocolRibo-seq and MBP mRNA-seq datasets were processed using Tophat 2.0 with default parameters (Trapnell et al., 2012). Files containing genomic coordinates (e.g., 5’ UTR, exon, intron) were obtained from TAIR 10. Reads were associated with a genomic feature using bedtools v2.23.0 (Quinlan and Hall, 2010) with overlap ≥80%.
DATA deposition
Request a detailed protocolThe genomics datasets were deposited at NCBI GEO under the accession number GSE82041.
Data availability
-
Endoplasmic reticulum as a hub organizing the activities of microRNAs and a subset of endogenous siRNAs in ArabidopsisPublicly available at the NCBI Gene Expression Omnibus (accession no. GSE82041).
-
Arabidopsis thaliana small RNAs sequences identified using high-throughput 454 sequencing technologyPublicly available at the NCBI Gene Expression Omnibus (accession no. GSE6682).
References
-
GERp95, a membrane-associated protein that belongs to a family of proteins involved in stem cell differentiationMolecular Biology of the Cell 10:3357–3372.https://doi.org/10.1091/mbc.10.10.3357
-
Unique functionality of 22-nt miRNAs in triggering RDR6-dependent siRNA biogenesis from target transcripts in ArabidopsisNature Structural & Molecular Biology 17:997–1003.https://doi.org/10.1038/nsmb.1866
-
psRNATarget: a plant small RNA target analysis serverNucleic Acids Research 39:W155–159.https://doi.org/10.1093/nar/gkr319
-
Comparative analysis of non-autonomous effects of tasiRNAs and miRNAs in Arabidopsis thalianaNucleic Acids Research 39:2880–2889.https://doi.org/10.1093/nar/gkq1240
-
Atypical RNA polymerase subunits required for RNA-directed DNA methylationNature Genetics 37:761–765.https://doi.org/10.1038/ng1580
-
Silencing by small RNAs is linked to endosomal traffickingNature Cell Biology 11:1150–1156.https://doi.org/10.1038/ncb1930
-
Isolation of plant polysomal mRNA by differential centrifugation and ribosome immunopurification methodsMethods in molecular biology 553:109–126.https://doi.org/10.1007/978-1-60327-563-7_6
-
A diverse and evolutionarily fluid set of microRNAs in Arabidopsis thalianaGenes & Development 20:3407–3425.https://doi.org/10.1101/gad.1476406
Article and author information
Author details
Funding
Shenzhen municipality (JCYJ20151116155209176)
- Shengben Li
Shenzhen municipality (KQCX2015033110464302)
- Shengben Li
National Natural Science Foundation of China (31210103901)
- Xiaofeng Cao
Howard Hughes Medical Institute
- Xuemei Chen
Gordon and Betty Moore Foundation (GBMF3046)
- Xuemei Chen
National Institutes of Health (GM061146)
- Xuemei Chen
Guangdong Innovation Research Team Funds (2014ZT05S078)
- Xuemei Chen
National Natural Science Foundation of China (91440105)
- Xuemei Chen
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Acknowledgements
We thank Drs. Natasha Raikhel and Detlef Weigel for sharing antibodies and genetic material. We thank Drs. Shou-Wei Ding and Wenrong He for comments on the manuscript. The work was supported by grants from Gordon and Betty Moore Foundation (GBMF3046), NIH (GM061146), NSFC (91440105), and Guangdong Innovation Research Team Fund (2014ZT05S078) to X Chen, NSFC (31210103901) to X Cao and the science technology and innovation committee of Shenzhen municipality (JCYJ20151116155209176, KQCX2015033110464302) to S Li.
Copyright
© 2016, Li et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 4,894
- views
-
- 1,409
- downloads
-
- 98
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Chromosomes and Gene Expression
- Neuroscience
Pathogenic variants in subunits of RNA polymerase (Pol) III cause a spectrum of Polr3-related neurodegenerative diseases including 4H leukodystrophy. Disease onset occurs from infancy to early adulthood and is associated with a variable range and severity of neurological and non-neurological features. The molecular basis of Polr3-related disease pathogenesis is unknown. We developed a postnatal whole-body mouse model expressing pathogenic Polr3a mutations to examine the molecular mechanisms by which reduced Pol III transcription results primarily in central nervous system phenotypes. Polr3a mutant mice exhibit behavioral deficits, cerebral pathology and exocrine pancreatic atrophy. Transcriptome and immunohistochemistry analyses of cerebra during disease progression show a reduction in most Pol III transcripts, induction of innate immune and integrated stress responses and cell-type-specific gene expression changes reflecting neuron and oligodendrocyte loss and microglial activation. Earlier in the disease when integrated stress and innate immune responses are minimally induced, mature tRNA sequencing revealed a global reduction in tRNA levels and an altered tRNA profile but no changes in other Pol III transcripts. Thus, changes in the size and/or composition of the tRNA pool have a causal role in disease initiation. Our findings reveal different tissue- and brain region-specific sensitivities to a defect in Pol III transcription.
-
- Biochemistry and Chemical Biology
- Chromosomes and Gene Expression
The mRNA 5'-cap structure removal by the decapping enzyme DCP2 is a critical step in gene regulation. While DCP2 is the catalytic subunit in the decapping complex, its activity is strongly enhanced by multiple factors, particularly DCP1, which is the major activator in yeast. However, the precise role of DCP1 in metazoans has yet to be fully elucidated. Moreover, in humans, the specific biological functions of the two DCP1 paralogs, DCP1a and DCP1b, remain largely unknown. To investigate the role of human DCP1, we generated cell lines that were deficient in DCP1a, DCP1b, or both to evaluate the importance of DCP1 in the decapping machinery. Our results highlight the importance of human DCP1 in decapping process and show that the EVH1 domain of DCP1 enhances the mRNA-binding affinity of DCP2. Transcriptome and metabolome analyses outline the distinct functions of DCP1a and DCP1b in human cells, regulating specific endogenous mRNA targets and biological processes. Overall, our findings provide insights into the molecular mechanism of human DCP1 in mRNA decapping and shed light on the distinct functions of its paralogs.